DASH vs MED · P/E 76, rev $13.72B vs rev $602.5M
DoorDash, Inc. Class A Common Stock (DASH) versus MEDIFAST INC (MED) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
MEDIFAST INC (MED) is a personal services company listed on NYSE.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported MED revenue for 2024-12-31 was $602.5M. Net income was $2.1M. Revenue was down 43.8% from 2023-12-31 to 2024-12-31. MED currently screens at market cap $125.3M.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. MED currently screens at market cap $125.3M.
Not investment advice. Open the DASH and MED stock pages for the full models.
Not investment advice.